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A B S T R A C T   
Background: Studying human ageing is of increasing importance due to the worldwide ageing population. 
However, it faces the challenge of lengthy experiments to produce an ageing phenotype. Often, to recreate the 
hallmarks of ageing requires complex empirical conditions that can confound data interpretation. Indeed, many 
studies use whole organisms with relatively short life spans, which may have little, or limited, relevance to 
human ageing. There has been extensive use of cell lines to study ageing in human somatic cells, but the 
modelling of human neuronal ageing is somewhat more complex in vitro. 
New Method: We cultured the well-characterised SH-SY5Y human neural cell line to produce high purity cultures 
of cells differentiated to express a neuronal phenotype, and designed a protocol to maintain these cells in culture 
until they accumulated biomarkers of cellular ageing. 
Results: Our data validate a novel and simple technique for the efficient differentiation and long-term mainte-
nance of SH-SY5Y cells, expressing markers of neuronal differentiation and demonstrating electrical activity in 
culture. Over time in vitro, these cells progressively accumulate markers of ageing such as enhanced production 
of reactive oxygen species and accumulation of oxidative damage. 
Comparison to Existing Methods: In comparison to existing techniques to model neuronal ageing our method is cost 
effective, requiring no specialist equipment or growth factors. 
Conclusions: We demonstrate that SH-SY5Y cells, grown under these culture conditions, represent a simple model 
of neuronal ageing that is amenable to cell biological, biochemical and electrophysiological investigation.   
1. Introduction 
Human neuroblastoma cell lines, such as SH-SY5Y, are a widely used 
in vitro model system, and have been utilised for a plethora of neuro-
science applications including cell viability assays (Jaworska-Feil et al., 
2010; Funakohi-Tago et al., 2018), neuronal ultrastructure (Cheng et al., 
2020), studies of neurophysiology (Tosetti et al., 1998; Öz and Çelik, 
2016) and testing of pharmacological preparations (Cheung et al., 2009; 
Jiang et al., 2018). These cells were originally derived from the SK-N-SH 
cell line which was sub-cloned three times to SH-SY, SH-SY5 and finally 
to the SH-SY5Y cell line. SH-SY5Y cells are often used in their undif-
ferentiated state and these cultures contain both floating and adherent 
cells. The adherent cells also adopt two distinctive phenotypes: 
neuroblast-like ‘N’ type cells, which express some neuron-specific 
biochemical markers such as dopamine-β-hydroxylase (Ross et al., 
1983) and non-neuronal substrate adhesive cells, ‘S’ type cells which 
exhibit an epithelial-like phenotype and do not express any neuronal 
markers (Encinas et al., 2000). To overcome the issues of having a 
heterogeneous cell population, these cells can be induced, by a variety of 
protocols, to differentiate into a mature neuron-like phenotype. This is 
characterised by exit from the cell cycle, the formation of a rounded cell 
body coupled with extension of neurites and expression of 
neuron-specific markers such as βIII-tubulin, NeuN, neurofilament and 
synaptic vesicle marker Sv2 (Agholme et al., 2010). These cells also form 
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synapses and demonstrate the ability to generate action potentials 
(Johansson, 1994; Öz and Çelik, 2016), and express both neurotrans-
mitters (Lopes et al., 2010) and their receptors (Adem et al., 1987; Qian 
et al., 2018). Development of protocols to differentiate these cells con-
tinues with refinement of the commonly used retinoic acid protocol 
(Simões et al., 2021) and variations to the addition of trophic support 
(Jun et al., 2020) reported very recently. 
Working with neural cell lines offers a number of advantages over 
primary neuronal culture. Deriving primary neurons from animals raises 
both cost and ethical issues, which is not the case with cell lines. In 
addition, a major advantage of working with SH-SY5Y cells is their 
human origin. Thus they express the human form of disease-relevant 
proteins within a cellular background of human protein and gene 
expression patterns. They can also be cultured in large quantities, which 
is advantageous for both biochemical manipulation and analysis. 
However, many current protocols for culturing these cells in a 
differentiated state are either inefficient (resulting in undifferentiated 
cells being maintained within the culture; Filograna et al., 2015), 
involve the use of trophic factor support that can influence intracellular 
signalling cascades (Encinas et al., 2000) or are technically demanding 
(Constantinescu et al., 2007). Neuronal differentiation can be attained 
by a variety of methods including retinoic acid-evoked differentiation 
(Encinas et al., 2000; Simpson et al., 2001; Constantinescu et al., 2007; 
Cheung et al., 2009) or staurosporin (Prince and Oreland, 1997), alone 
or in combination with growth factors (Jämsä et al., 2004). For instance, 
retinoic acid (10 μM) induces growth inhibition of around 55% 
(compared to untreated controls) after 7 days of treatment suggesting 
that a significant number of cells remain in the cell cycle following 
retinoic acid exposure (Filograna et al., 2015). For fully differentiated 
cells, mitosis needs to be eliminated and thus retinoic acid alone is 
insufficient to fully differentiate these cells. To counteract this exoge-
nous trophic factors such as BDNF are often used (Teppola et al., 2016). 
Beyond differentiation, the lack of endogenous neurotrophic factors 
in neuronal cultures due to the absence of glial cells can result in 
apoptosis and therefore it has become common practice to add growth 
factors to culture media. However, the use of trophic factors is poten-
tially problematic as signalling via these factors can protect cells from 
neurotoxicity and for the purposes of examining cell death and neuro-
protection this can present a significant challenge. The neurotrophin, 
nerve growth factor (NGF), activates a PI3kinase/ Akt signalling cascade 
to promote cell survival (Yano and Chao, 2000) and thus determining 
the effects of exogenous neuroprotective agents on this signalling 
pathway is difficult if it is already activated. A diversity of potential 
therapeutics for neurodegeneration and spinal cord repair activate this 
signalling cascade including NGF per se (Fahnestock and Shekari, 2019), 
leptin (Doherty et al., 2008; Malekizadeh et al., 2017), and quercetin 
(Çiftçi et al., 2016; Zaplatic et al., 2019). The most commonly used 
neurotrophin in SH-SY5Y cultures is BDNF and indeed it is often used to 
help differentiate as well as support the cells in culture. However, in-
hibition of the cell cycle is unreliable when following this protocol 
(Teppola et al., 2016). Furthermore, like NGF, BDNF activates common 
survival pathways such as PI3kinase/ Akt (Segal, 2003). 
A previous study detailed a method for culturing neuroblastoma cells 
without the need for trophic support (Constantinescu et al., 2007). 
Following retinoic acid differentiation, cells were exposed to a cocktail 
of mitotic inhibitors (fluorodeoxyuridine, cytosine arabinoside and 
uridine) and were incubated in a culture system wherein a perfusion 
pump was used to maintain the cells. However, although this generated 
pure differentiated cultures of SH-SY5Y cells, the perfusion pump in-
troduces technical complexity. Furthermore, the use of the mitotic in-
hibitor cocktail introduces more confounding factors for cell viability. 
Cytosine arabinoside is neurotoxic to rat primary sympathetic neurons 
(Martin et al., 1990) and cerebellar granule cells (Paterson et al., 1998). 
In contrast, fluoroxyuridine has not been previously linked to 
neurotoxicity. 
Here we present a simplified culture method, allowing 
differentiation and maintenance of SH-SY5Y neuroblastoma cells, using 
a combination of retinoic acid followed by 5-fluorodeoxyuridine to 
inhibit proliferation of undifferentiated cells. Maintaining the SH-SY5Y 
cells in defined culture medium allowed establishment of a neuronal 
phenotype and electrical signalling. Further, accumulation of oxidative 
damage markers, previously used to define an ageing phenotype for in 
vitro primary neurons (Lesuisse and Martin, 1992), occurred with long- 
term culture in these conditions. Thus we present a novel and simple, 
neurotrophin-free technique for efficient differentiation, and long-term 
culture, of SH-SY5Y cells and illustrate the development of an ageing 
phenotype in these cultures. 
2. Materials and methods 
2.1. Materials 
Unless otherwise stated all chemical and reagents used in this study 
were purchased from Sigma Aldrich (UK). 
2.2. Maintenance of SH-SY5Y cells 
SH-SY5Y (European Collection of Cell Cultures) cells were defrosted 
and grown in accordance with cell bank protocols. Ethical permission to 
use these cells within the University of St Andrews for the purposes for 
medical and scientific research was obtained from the School of Psy-
chology and Neuroscience ethics committee (Ref PS11189). Cells were 
grown to confluence in tissue culture flasks in Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with 10% iron-fortified new-born calf 
serum (Cosmic Calf Serum, Fisher, UK). Iron-fortified calf serum con-
tains up to four times the amount of transferrin and available iron as 
fetal calf sera supporting the rapid proliferation of SH-SY5Y cells prior to 
differentiation as iron is crucial for the bioenergetics of proliferating 
cells (Pourcelot et al., 2015). Cells were trypsinised in 0.05% trypsin 
(Worthington’s, USA) in calcium and magnesium free buffer solution, 
and plated on either 96 well culture plates (10,000 cells per well; Nunc, 
vwr, UK) or on 0.0005% w/v poly-L-lysine-coated 13 mm diameter 
borosilicate glass coverslips (50,000 cells per coverslip), in DMEM 
supplemented with 4500 mg/L D-glucose, 10 mg/ml penicillin/ strep-
tomycin and 10% iron-fortified new-born calf serum. All cells used in 
these experiments were of passage number 3–20. 
2.3. Culture conditions 
When cells had reached 70% confluence, they were stimulated with 
retinoic acid (10 μM) to induce differentiation to a neuronal phenotype, 
and the serum content of the medium reduced to 1%. After 5 days, 
medium was changed to one containing mitotic inhibitor (5-fluo-
rodeoxyuridine (5-fdu; 18 μM (Malekizadeh et al., 2017)) and cells were 
maintained in this medium for the duration of the experiment, changing 
100% of the medium every 3–4 days. When changing the medium, the 
cultures were washed twice in DMEM to remove any adherent dead 
cells. For experiments using serum-containing medium, this mainte-
nance medium was DMEM supplemented with 4500 mg/L D-glucose, 10 
mg/ml penicillin/ streptomycin, 18 μM 5-fdu and 1% iron-fortified 
new-born calf serum; and for experiments using defined medium, the 
cells were maintained in DMEM supplemented with 4500 mg/L 
D-glucose, 10 mg/ml penicillin/ streptomycin, 18 μM 5-fdu and 2% 
serum replacement − 2 (SR-2; Sigma UK). Cells were kept in a humidi-
fied incubator at 37 ◦C and 5% CO2. Throughout this study, time in 
culture is expressed as number of weeks in vitro post removal of retinoic 
acid. 
2.4. Immunocytochemistry 
Cells were fixed in neutral buffered formalin for 15 min followed by 
repeat phosphate buffered saline (PBS) washes and blocking of non- 
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specific antibody binding using PBS with 0.1% triton X-100 (PBS-T) and 
10% heat inactivated horse serum. Cells were incubated in primary 
antibody at 4 oC overnight at an appropriate dilution for each antibody 
(Table 1). Thereafter they were washed in PBS-T and incubated for one 
hour in the fluorescent secondary antibody at room temperature 
(Table 1). Coverslips were mounted in fluorescent mounting medium 
(1% w/v N-propyl-gallate dissolved 80% v/v glycerol; 20% v/v PBS) 
and imaged using a Zeiss Axio MR2 with Zen image analysis software. 
2.5. Electrophysiology 
Cells were grown on poly-L-lysine-coated borosilicate glass cover-
slips in DMEM supplemented with 2% SR-2 for 4 weeks post differen-
tiation. For electrophysiological recordings, coverslips containing cells 
were immersed in a recording chamber continuously superfused with 
artificial cerebrospinal fluid (approximately 1 ml per second; gassed 
with 95% O2 and 5% CO2 at room temperature, ~20 ◦C). Whole-cell 
patch-clamp recordings were established under infrared-differential 
interference contrast microscopy using borosilicated glass microelec-
trodes (3–5 MΩ) filled with intracellular solution. Signals were ampli-
fied and filtered (4 kHz low-pass Bessel filter) with a MultiClamp 700B 
amplifier (Molecular Devices, Sunnyvale, CA, USA) and acquired at ≥
10 kHz using a Digidata 1440AA/D board and pClamp software (Mo-
lecular Devices). The recording aCSF contained (in mM): 127 NaCl, 3 
KCl, 1.25 NaH2PO4, 1 MgCl2, 2 CaCl2, 26 NaHCO3, 10 glucose. The 
intracellular solution for patch-clamp recordings contained (in mM): 
140 KMeSO4, 10 NaCl, 1 CaCl2, 10 HEPES, 1 EGTA, 3 Mg-ATP and 0.4 
GTP-Na2 (pH 7.2–7.3, adjusted with KOH). 
2.6. Determination of viability 
Initial determination of cell wellbeing was carried out by visual in-
spection with phase contrast microscopy and recorded using a Nikon 
Coolpix digital camera linked to a Nikon TS100F inverted microscope. 
To estimate cell number per field of view, cells were fixed in neutral 
buffered formalin and labelled using 500 ng/ml 4’− 6-diamidino-2- 
phenylindole (DAPI) in PBS before imaging under a Zeiss Axio MR2 
fluorescent microscope. Data from 5 randomly selected fields of view 
from 7 independent experiments and 2 durations of culture were 
collected and presented as average number of DAPI positive nuclei per 
field of view. Lactate dehydrogenase (LDH) is a cytoplasmic enzyme that 
is released upon cell membrane rupture and thus the concentration of 
LDH in the culture medium can be used to determine the level of cell 
death in a culture. Determination of LDH levels in the culture medium 
was carried out as described previously (Oldreive et al., 2010). 
2.7. Determination of mitochondrial redox capacity 
To ascertain mitochondrial redox capacity, mitochondrial activity 
was analysed via the 3-(4,5-dimethylthiazol-2-yl)− 2,5-diphenylte-
trazolium bromide (MTT) assay as described previously (Doherty, 
2007). The resulting purple azo-dye was detected at 570 nm with a 
Biohit BP800 plate reader. Data was expressed as percentage mito-
chondrial activity relative to that detected in cells 2 weeks post 
differentiation. 
2.8. Western blot 
Proteins from cultures were extracted into 500 µl tris-buffered saline 
containing protease inhibitor cocktail (Set II, Merck, UK). Protein sam-
ples were run on a 10% SDS-polyacrylamide gel (NuSep) giving a final 
protein concentration per well of 20 µg/µl as determined by the Bradford 
assay, and transferred to a nitrocellulose membrane. Membranes were 
blocked in 5% w/v dried skimmed milk in Tris buffered saline (TBS) +
0.1% v/v triton X-100 prior to incubation with the mouse-anti-alpha 
tubulin antibody overnight at 4 ◦C. Primary antibody binding was 
detected using a horseradish peroxidase (HRP)-conjugated secondary 
antibody at 1:10,000 v/v in TBS-T and visualised using chem-
iluminescence ECL substrate (Pierce) and imaged with a GelDoc Imager 
it2 with Vision Works software. 
2.9. Oxyblot 
Protein samples were chemically denatured by the addition of 12% 
w/v sodium dodecyl sulphate in deionized water for 15 min. The sam-
ples were then mixed with dinitrophenyl residues according to the 
manufacturer’s protocol (Merck, UK), and incubated for 20 min, then 
neutralisation buffer was then added to halt the reaction. 10 µg/µl of 
each sample was loaded onto a gel and the remainder of the assay was 
carried out as per the manufacturer’s instructions with the intensity of 
the bands determined using Image J software. 
2.10. Statistical analysis 
Results are presented as mean ± standard error of the mean of 
triplicate samples from at least three separate experiments. Data was 
screened for normality using a Kolmogorov–Smirnov test. Statistical 
significance was determined using students t-test where data was nor-
mally distributed and Wilcoxon signed ranked test for non-parametric 
data. 
3. Results 
3.1. Differentiated SH-SY5Y cells treated with mitotic inhibitor are viable 
in culture for 4 weeks 
To determine whether differentiated SH-SY5Y cells could survive in 
long term culture without exogenous neurotrophic support, and in the 
absence of a peristaltic pump, cultures of retinoic acid-treated cells were 
followed for up to 4 weeks post-differentiation. These cells were main-
tained in either SR-2-supplemented, 1% iron fortified calf serum- 
supplemented or serum-free medium with mitotic inhibitor. Two 
weeks after retinoic acid withdrawal there were clear differences in the 
number of cells surviving in the cultures (Fig. 1A) with no cells surviving 
in serum-free cultures (not shown; n = 3). However, 2 weeks post- 
differentiation there were viable cells with a neuronal morphology 
and robust process outgrowth in cultures maintained in either 1% iron- 
fortified calf serum (Fig. 1Ai) or SR-2-supplemented cultures (Fig. 1Aii). 
After 4 weeks in culture, the on-going survival in cultures maintained in 
1% serum was unreliable with 60% of cultures retaining viable neurons 
at 4 weeks post differentiation, and 40% of cultures in which all neurons 
had died prior to this (n = 5). In contrast, cells maintained in DMEM 
supplemented with 2% SR-2 remained viable 4 weeks after withdrawal 
of retinoic acid. Under phase contrast microscopy, phase bright cell 
bodies and multiple processes are observed in SR-2-maintained cultures 
imaged both 2 weeks (Fig. 1Bi) and 4 weeks (Fig. 1Bii) after retinoic acid 
treatment ended. There was also a marked increase in the number of 
processes visible in the cultures between 2 and 4 weeks. To further 
examine the cell number at these two time-points, we stained cultures 
with the DNA dye, DAPI and counted the number of DAPI positive nuclei 
Table 1 
Details of antibodies used in these experiments. Details of dilutions, applications 
and company these antibodies were purchased from are given.  
Antibody Dilution Application Manufacturer 
Mouse anti-βIII-tubulin 1: 1000 ICC Promega, UK 
Rabbit anti-4- 
hydroxynonenol 
1:500 ICC Insight Biotechnologies, 
UK 
Mouse anti-synapsin 1:1000 ICC Cell Signalling 
Technologies 
Mouse anti-α-tubulin 1:5000 Western 
blot 
Sigma Aldrich, UK  
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per field of view (63x magnification) in SR-2-supplemented cultures. 
Analysis of these counts revealed that there was no significant difference 
in the number of cells per field of view between 2 and 4 weeks (9.086 +
1.157 at 2 weeks and 8.068 + 1.676 at 4 weeks; n = 7 plate downs; P >
0.05; Fig. 1C). To further investigate levels of cell death within these 
cultures, LDH release into the culture medium, as a measure of mem-
brane integrity, was determined. There were significantly less dying 
cells in the 4 week cultures (0.23 ± 0.007 a.u.) compared to 2 week 
cultures (0.28 ± 0.008 a.u.; n = 7; P < 0.001; Fig. 1D). Thus levels of cell 
death are not increasing with time in vitro implying that the cell popu-
lation has stabilised by this time in culture. We conclude that retinoic 
acid-differentiated SH-SY5Y cells are viable for at least 4 weeks after 
cessation of retinoic acid treatment when cultured in DMEM supple-
mented with 2% SR-2 and 18 μM 5-fdu. This is the medium that was used 
for all further experiments. 
Fig. 1. Differentiated SH-SY5Y cells treated with mitotic inhibitor are viable in culture for 4 weeks. (A) Phase contrast photomicrographs of SH-SY5Y cells 2 weeks 
post differentiation with retinoic acid and maintained in 1% iron-fortified calf serum-containing (Ai) or SR-2-supplemented medium (Aii). Phase bright cell bodies 
and extensive networks of processes are observed revealing viable cells with a neuronal morphology. Images are taken at 40x magnification and scale bar represents 
50 µm. (B) Images of neurons maintained in SR-2-supplemented medium for 2 weeks (Bi) or 4 weeks (Bii) post differentiation. (C) Bar chart of DAPI counts of cell 
nuclei in culture 2 week and 4 week post-differentiation and (D) bar chart of lactate dehydrogenase release into the culture medium at these time-points. The means 
and standard errors of the means of seven experiments established in triplicate are shown. *** represents statistical significance (P < 0.001). 
Fig. 2. Differentiated SH-SY5Y cells treated with mitotic inhibitor express neuron specific markers. (A) Images of undifferentiated (Ai) and cultures 2 weeks post- 
differentiation (Aii) immunocytochemically labelled to detect βIII-tubulin expression, and negative control image (Aiii). Images were taken at 63 x magnification and 
scale bar represents 5 µm. (B) Images of undifferentiated (Bi) and 2 week cultures (Bii) immunocytochemically labelled to determine tyrosine hydroxylase expression, 
and negative control image (Biii). Images were taken at 40x magnification and scale bar represents 10 µm. 
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3.2. Differentiated SH-SY5Y cells treated with mitotic inhibitor express 
neuron specific markers 
Although it is well known that exposure to retinoic acid induces 
differentiation and the expression of neuron-specific markers in SH- 
SY5Y cells (Constantinescu et al., 2007; Korecka et al., 2013; Simões 
et al., 2021), the expression of these markers in our system remained to 
be determined; this information gives an indication of the purity of the 
cultures. Therefore SH-SY5Y cells were fixed for immunocytochemistry 
when undifferentiated, or 2 weeks after retinoic acid-induced differen-
tiation and the expression of βIII-tubulin detected using immunocyto-
chemistry. Clear immunofluorescence can be seen in βIII-tubulin-stained 
cultures in contrast to the control condition in which the primary anti-
body has been omitted. Analysis of images stained with βIII-tubulin 
revealed that virtually all of the differentiated cells in our cultures 
expressed this neuronal marker whereas staining levels in the undiffer-
entiated cells were similar to those seen in the control lacking primary 
antibody (Fig. 2A). In addition, because retinoic acid differentiation is 
known to induce a dopaminergic phenotype (Korecka et al., 2013), we 
stained the cultures for the presence of tyrosine hydroxylase (TH), the 
rate-limiting enzyme in dopamine biosynthesis. Robust TH immunore-
activity was detected in the differentiated cultures at 2 weeks (Fig. 2Bii) 
whereas the levels in the undifferentiated cells (Fig. 2Bi) were much less. 
Thus our protocol induces the differentiation of these cells to produce 
neuronal markers and the expression of these is maintained once reti-
noic acid is withdrawn. 
3.3. Cells in these cultures form synapses and exhibit electrophysiological 
activity 
One of the defining features of a neuronal population is the ability to 
form synaptic connections and a functional neuronal network. Immu-
nocytochemical staining for the synaptic marker, synapsin, was used to 
determine whether these cells formed synapses with one another after 2 
weeks in culture. Clear punctate immunolabelling was observed on the 
processes extended by the fully differentiated SH-SY5Y cells (Fig. 3Ai) in 
contrast to the negative control lacking primary antibody (Fig. 3Aii). 
Undifferentiated SH-SY5Y cells do not show this pattern of immunore-
activity (Supplementary Fig. 1). This indicates that by 2 weeks post 
retinoic acid exposure the cells are expressing a synaptic marker in a 
pattern that suggests the formation of functional synapses. 
Whilst the presence of synaptic markers indicates that the SH-SY5Y 
cells are electrically active under these culture conditions, it does not 
provide evidence of neurons with the functional capacity to assemble 
neuronal networks. Therefore we next performed whole-cell patch- 
clamp electrophysiological recordings from cultures of 4 week old cells 
to assess their functional properties (Fig. 3B–C). Recordings performed 
in voltage-clamp mode demonstrated fast-inactivating sodium currents 
in response to a series of depolarising voltage steps (10 ms duration) 
performed from a holding potential of − 60 mV (Fig. 3B). Recordings 
conducted in current-clamp mode revealed that differentiated SH-SY5Y 
cells are able to generate repetitive trains of action potentials in response 
to depolarising current steps (1 s duration; Fig. 3C). Taken together, 
these data demonstrate that these cells have differentiated into a func-
tional neuronal phenotype. 
3.4. SH-SY5Y cells exhibit decreased mitochondrial activity and 
increased levels of ROS with time in culture 
A number of methods have been proposed to age primary neurons in 
culture (Lesuiss and Martin, 2002; Burrinha et al., 2021). Although there 
is no definitive time point at which cultures can be considered aged, the 
Fig. 3. Cells in these cultures form synapses and exhibit electrophysiological activity. (A) Images of cultures 2 weeks post-differentiation (Ai) immunocytochemically 
labelled to determine synapsin expression and negative control image (Aii). Images were taken at 40 x magnification and scale bar represents 10 µm. (B&C) 
Representative whole-cell patch-clamp recordings from cells 2 weeks post differentiation showing (B) inward sodium currents in response to depolarising voltage 
steps and (C) repetitive firing of action potentials in response to current injection. Voltage-clamp and current-clamp protocols are depicted beneath raw data in (B) 
and (C). 
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progressive accumulation of oxidative damage with time is proposed as 
a valid in vitro model of the in vivo build-up of oxidatively damaged 
cellular constituents observed in ageing ( Kruman et al., 1997; Valava-
nidis et al., 2009). To determine if there was an increase in ROS gen-
eration over time in our cultures, we used the fluorescent dye H2-DCFDA 
(10 µM), which fluoresces when oxidised by ROS. Cells were imaged at 2 
and 4 weeks post retinoic acid differentiation using confocal microscopy 
(Fig. 4B), and the mean fluorescent intensity per cell measured at each 
time-point (Fig. 4A). The results show a clear increase in the intensity of 
H2-DCFDA fluorescence between 2 and 4 weeks post differentiation 
detecting 862,500 ± 149,700 a.u. per cell in 4 week cultures. This is 
significantly higher than that observed in 2 week cultures (164, 
100 ± 21,170; n = 8 separate cultures; P < 0.001) Thus levels of ROS 
generation increase with time in culture. 
Mitochondria are the major site of ROS generation within the cell, 
and with age, mitochondrial redox capacity is reduced, which goes some 
way to explain why ROS levels rise with age and damage cellular con-
stituents (Liang and Godley, 2003). This can be measured using MTT 
assay (Shearman et al., 1995). Thus we ascertained mitochondrial redox 
function in the cells 2 and 4 weeks post differentiation. The data reveal 
that there was a 73.25 + 5.62% decrease in mitochondrial redox ca-
pacity between 2 and 4 weeks in vitro (Fig. 4A; n = 7; P < 0.001), which 
cannot be attributed to a decrease in neuronal viability (see Fig. 1). 
These cultures exhibit a decrease in redox capacity between 2 and 4 
weeks post differentiation coupled to a concomitant rise in ROS 
generation. 
3.5. SH-SY5Y cells exhibit accumulation of oxidative damage with time in 
culture 
Although reduced redox capacity and enhanced generation of ROS 
have been linked to ageing (Liang and Godley, 2003), it is the accu-
mulation of oxidatively-modified intracellular components that is 
believed to underpin the phenotypic alterations associated with age 
(Vanhooren et al., 2015). 
To determine whether we observe enhanced lipid peroxidation with 
time in culture, immunocytochemistry was used to detect 4-hydroxyno-
nenol (HNE). Formation of HNE results from oxidation of phospholipids 
containing ω-6 polyunsaturated fatty acyl chains and therefore HNE 
presence is a widely used as a marker of oxidatively damaged lipids 
(Spickett, 2013). Samples were stained 2 or 4 weeks after retinoic acid 
differentiation and a clear increase in immunoreactivity between the 
two time points was observed (Fig. 4Di-ii), and enhanced immunore-
activity is seen at both timepoints compared to controls lacking the 
primary antibody (Fig. 4D). 
Protein oxidation is a well-established feature of ageing and can be 
detected using oxyblot to identify carbonyl groups introduced into 
proteins by oxidative reactions mediated by ROS. There is a marked 
increase in the intensity of protein bands derived from 4 week as 
compared to 2 week cultures (Fig. 4E). Quantification of the band in-
tensity from oxyblot revealed that there was a significant increase in 
protein oxidation between the 2 time-points. Thus a lane intensity of 
4438.3 + 595.8 a.u. was detected for 2 week protein samples and of 
14598.10445 + 4219.4 for 4 week protein samples representing around 
a 3-fold increase in protein oxidation (n = 11; P < 0.01). Taken together 
our data demonstrate that these cells are accumulating oxidative dam-
age over time in culture. 
Fig. 4. SH-SY5Y cells exhibit decreased mitochondrial activity and increased levels of ROS with age. (A) Quantification of fluorescent intensity in H2-DCMFA 
labelled cultures 2 weeks and 4 weeks post-differentiation. The means and standard errors of the means of 8 separate experiments established in duplicate and with at 
least five fields of view imaged per coverslip are shown. *** represents statistical significance (P < 0.001). (B) Images of 2 (Bi) and 4 (Bii) week cultures stained with 
the fluorescent dye H2-DCFDA to demonstrate ROS levels. Images were taken at 20 x magnification and scale bar represents 25 µm. (C) Bar chart of relative levels of 
mitochondrial redox capacity in cultures 2 weeks and 4 weeks post-differentiation. The means and standard errors of the means of 6 separate experiments are shown. 
*** represents statistical significance (P < 0.001). (D) Images of cultures immunocytochemically labelled to determine HNE expression cultures 2 weeks (Di) and 4 
weeks (Dii) post-differentiation and negative control image (Diii). Images were taken at 40 x magnification and scale bar represents 25 µm. (E) Representative image 
of an oxyblot to detect protein oxidation in cultures 2 weeks and 4 weeks post-differentiation and image of a corresponding western blot of these samples 
demonstrating α-tubulin expression as a loading control. (F) Quantification of the amount of oxidatively modified protein in cultures 2 weeks and 4 post- 
differentiation. The means and standard errors of the means of 11 separate experiments are shown. ** represents statistical significance (P < 0.01). 
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4. Discussion 
The neuroblastoma cell line SH-SY5Y, is commonly used in neuro-
degeneration research as they express a neuronal phenotype and, as a 
human cell line, avoid concerns regarding cross-species effects, solely 
expressing human proteins (Cheung et al., 2009; Zhang et al., 2010). 
Retinoic acid-induced differentiation is by far the best categorised pro-
tocol for differentiation and promotes upregulation of neuronal markers 
and neurite outgrowth (Jämsä et al., 2004; Korecka et al., 2013; Simões 
et al., 2021). By using retinoic acid as a differentiating agent and a 
simple protocol thereafter to eliminate any remaining undifferentiated 
cells, we have established a highly pure culture of cells expressing a 
neuronal phenotype with the functional capacity to form a neuronal 
network, and which can be maintained in vitro for extended periods until 
they accumulated age-related biomarkers. 
Previous research has suggested that whilst differentiating the cells 
with retinoic acid gives rise to a neuronal phenotype, not all cells exit the 
cell cycle (Filograna et al., 2015). However, subsequent treatment with 
growth factors gives rise to reduction in mitosis, promotes neurite 
outgrowth and increased expression of neuron specific markers such as 
MAP2, NeuN and βIII-tubulin (Encinas et al., 2000; Constantinescu et al., 
2007; Agholme et al., 2010). Furthermore, addition of growth factors 
increases synaptic vesicle marker expression which is indicative that 
these cells are capable of firing action potentials. Therefore, in isolation 
retinoic acid is useful to induce differentiation but additional culture 
conditions are required for long term maintenance. 
For undifferentiated cells, fetal bovine serum is used to supplement 
culture media as it encourages cell proliferation and contains a cocktail 
of growth factors which support survival and proliferation 
(Gstraunthaler, 2003). Here we use iron-fortified calf serum due its 
higher levels of free iron and transferrin further supporting the cells 
during the proliferative phase (Pourcelot et al., 2015). To encourage the 
differentiation of cell lines, serum concentration is routinely reduced to 
between 1% and 5% inhibiting proliferation and supporting differenti-
ation (Ferruzza et al., 2013). In this study we lowered the iron-fortified 
calf serum concentration from 10% to 1% during the differentiation 
phase of the protocol and thereafter switched cells into medium that was 
either serum-free, contained 1% iron-fortified calf serum or a commer-
cially available serum replacement (SR-2), which has previously been 
shown to support primary neurons in vitro (Doherty et al., 2013). We 
have shown that optimal cell survival was achieved using this defined 
serum replacement and there is no need for non-defined ser-
um-containing media or for supplementation with exogenous growth 
factors. This also reduces the use of animals in the generation of reagents 
for such studies. It has been widely reported that without subsequent 
treatment with neurotrophins such as NGF or brain-derived neuro-
trophic factor (BDNF) these cultures exhibit enhanced levels of cell 
death and lower expression of neuron specific markers (Jämsä et al., 
2004; Agholme et al., 2010). In contrast we do not observe a marked 
increase in cell death between 2 and 4 weeks in culture suggesting that 
within this timeframe these cells are able to survive in the absence of 
neurotrophic support. Finally, the use of growth factors in cell culture, 
especially for long term culture, is a costly endeavour and therefore we 
opted to develop a protocol without exogenous trophic factor support. 
To conclude, we have shown that even in the absence of neurotrophin 
supplementation we have given rise to fully differentiated neural culture 
which expresses neuronal and synaptic markers and that remain viable 
across 4 weeks in culture. 
Importantly, to verify that our cells were excitable, a defining feature 
of neurons, we conducted electrophysiological recordings. We found 
that our cells express appropriate ion channels and are capable of firing 
repetitive trains of action potentials in response to current stimuli. This 
reveals that this culture model is useful for generating highly pure 
neuronal cultures that are amenable to sensitive functional analyses, 
which have been used to reveal some of the earliest perturbations in 
models of progressive neurodegenerative diseases such as Amyotrophic 
Lateral Sclerosis (e.g. Devlin et al., 2015). 
Current theories of ageing suggest that as neurons age, they accu-
mulate damage through the activities of ROS and thus express higher 
levels of oxidatively-modified DNA, RNA and proteins, rendering them 
less efficient or inactive. A variety of models are currently used to study 
ageing in vivo including longitudinal human studies such as the Fra-
mingham cohort (Elias et al., 2000), rodent (Liao and Kennedy, 2014), 
avian (Travin and Feniouk, 2016) and invertebrates (Torgovnick et al., 
2013) and all of these require extended experimental protocols due to 
complexity and/or lifespan. The use of cell culture models of ageing in 
non-neuronal cells is widespread (Salama et al., 2014; Childs et al., 
2015) but the use of ageing primary neuronal cultures has not been 
widely adopted by the scientific community. Long term maintenance of 
neuronal cultures can be problematic and involve complex culture 
media, which can confound data analysis from these models. Further-
more, the need to use animal donors of this tissue for these experiments 
adds the additional factors of ethical issues and the nature of cells, in 
that lack human-specific proteins. Using the method developed herein, it 
is now possible to study the underlying mechanisms of cellular ageing 
and to examine potential pharmacological means of preventing the 
deleterious effects of ageing in human cells. Thus, we have demon-
strated that these cells show signs ageing such as oxidative damage to 
both protein and lipids as well as a decrease in mitochondrial redox 
capacity and an increase in the generation of ROS. 
As neurons are post-mitotic cells, the potential for neurons to show 
senescence has received little attention in the scientific literature as in 
their post-mitotic state they cannot exhibit replicative senescence. 
Whilst our cells are also post-mitotic and we similarly did not address 
senescence here, this model could be used to investigate neuronal se-
nescent markers in future studies. For instance, post-mitotic mature 
neurons can develop a senescence-like phenotype. Thus mature neurons 
of aged mice exhibit DNA damage, activated p38MAPkinase, high ROS 
production and oxidative damage, interleukin IL-6 production, hetero-
chromatinization and senescence-associated β-galactosidase activity, 
with the number of these senescence-like neurons increasing with age 
(Jurk et al., 2012). With evidence that both Alzheimer’s-associated tau 
(Musi et al., 2018) and amyloid (Wei et al., 2016) can induce cellular 
senescence, investigations of their effects on these aged neurons, with 
respect to senescent markers could prove interesting. 
An emerging model for studying neurons in vitro is the use of 
inducible pluripotent stem cells (iPSCs), which can be differentiated to a 
neuronal phenotype. These can have additional benefits over the SH- 
SY5Y cells as they can be derived from both patients and healthy vol-
unteers (for neurological disorders). This technology has the potential to 
accurately model human disease in vitro, however these cultures require 
extensive, expensive and complex protocols. Furthermore as this tech-
nology remains under development the transformation efficiency for a 
given cell type can be as low as 1% (Robinton and Daley, 2012). Thus 
current iPSC cultures are heterogeneous to varying degrees whether 
containing a mix of neurons and glia or of neuronal sub-types (Srikanth 
and Young-Pearse, 2014). Furthermore, the reprogramming required to 
establish iPSC cultures re-sets the cells to an embryonic phenotype 
which raises issues for modelling late-onset disorders. Attempts have 
been made to overcome this, for instance expressing progerin in these 
cells to induce phenotypic ageing in Parkinson’s models (Miller et al., 
2013). Despite telomeric shortening being most commonly associated 
with aging of somatic cells, downregulation of telomerase and telomere 
shortening during neural differentiation allows iPSCs to be converted to 
neurons that more accurately model the aged neurons most commonly 
affected by neurodegeneration (Vera et al., 2016). Finally, to circumvent 
the need to re-programme to the embryonic state, the direct transcrip-
tion factor-based conversion of fibroblasts into induced neurons (iNs) is 
emerging as a promising means of establishing aged human neurons in 
vitro (Pang et al., 2011) and these cells retain transcriptomic profiles 
akin to their aged origins (Mertens et al., 2015). Together these findings 
suggest that iPSC technology still offers a valuable avenue in modelling 
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human neurological disorders in vitro and better techniques for working 
with these cells are emerging regularly. 
Another interesting and emerging technology of importance to 
neuroscience is the development of three-dimensional (3D) culture 
systems, which are usually based on iPSCs. These are complex systems 
wherein post-iPSC differentiation organoids form (which can be facili-
tated by exogenous scaffolds (Mansour et al., 2018)) and these are 3D 
self-organized structures with both morphological and functional char-
acteristics that are similar to the brain (Papaspyropoulos et al., 2020). 
Whilst the technology continues to develop no specific attempts to age 
these organoids have been reported and the complexity of the system 
makes these time-consuming and technically demanding to develop. 
In contrast our SH-SY5Y cultures can be rapidly and inexpensively 
cultured in large numbers and obtain phenotypic markers of ageing 
within a few short weeks whilst requiring minimal maintenance and 
manipulation. We propose that they offer a simple and inexpensive 
model for biochemical and cellular investigations of ageing in vitro. 
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